Showing results (71-80 of 526) with videos related to

Sort By:
Pageof 53
Canadian Journal of Physiology and Pharmacology|January 1, 1983
The occurrence of two hepatic microsomal sites for amobarbital hydroxylationP A Reilly, B K Tang, D J Stewart, et al.
British Journal of Clinical Pharmacology|April 1, 1986
Effect of allopurinol on caffeine disposition in manD M Grant, B K Tang, M E Campbell, et al.
Biochemical Pharmacology|April 15, 1987
Biotransformation of caffeine by microsomes from human liver. Kinetics and inhibition studiesD M Grant, M E Campbell, B K Tang, et al.
Biochemical and Biophysical Research Communications|June 15, 1994
Caffeine biotransformation in human hepatocyte lines derived from normal liver tissueE A Roberts, K N Furuya, B K Tang, et al.
Pharmacology & Toxicology|July 1, 1990
Sparteine metabolism capacity in human liver: structural variants of human P450IID6 as assessed by immunochemistryR F Tyndale, F J Gonzalez, J P Hardwick, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 1989
Haloperidol reduction can be assayed in human red blood cellsT Inaba, W Kalow, T Someya, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitroD Wu, S V Otton, P Morrow, et al.
European Journal of Clinical Pharmacology|October 16, 2001
Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamineS K Sy, B K Tang, A Pastrakuljic, et al.
Clinical Pharmacology and Therapeutics|January 1, 1995
Low CYP1A2 activity in rural Shona children of ZimbabweC M Masimirembwa, M Beke, J A Hasler, et al.
Molecular Pharmacology|July 1, 1991
Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6R F Tyndale, R Sunahara, T Inaba, et al.
Pageof 53